Product Information
MICROGESTIN 21 1-20 TABLET is a generic product labeled by Dr. Reddy's Laboratories Inc., priced at $0.1812 per EA under NDC 75907008421. Its NADAC has been published 97 times since Nov 27, 2024.
FDA first approved this application on Dec 4, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Dr. Reddy's Laboratories Inc.NDC
75907008421
Classification
Generic
Dosage Form
KIT
Effective Date
9/23/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA202995FDA Approved
12/4/2013
TE Code
AB
On Market Since
6/1/2024
Price Statistics
The NADAC for MICROGESTIN 21 1-20 TABLET has been published 97 times since Nov 27, 2024, and over the history we have for it it has risen 11.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1812 per EA |
|---|---|
| All-time high | $0.1842 (Sep 16, 2026) |
| All-time low | $0.1619 (Nov 27, 2024) |
| 52-week high | $0.1842 |
| 52-week low | $0.1652 |
| Median price | $0.1722 |
| Average price | $0.1729 |
| Largest weekly change | +12.6% (Dec 18, 2024) |
| Weeks tracked | 97 |
| Tracking since | Nov 27, 2024 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Dr. Reddy's Laboratories Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Norethindrone Acetate/Ethinyl Estradiol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MICROGESTIN 21 1-20 TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MICROGESTIN 21 1-20 TABLET, manufactured by Dr. Reddy's Laboratories Inc., is $0.1812 per EA (NDC 75907008421), effective Sep 30, 2026.
How has the price of MICROGESTIN 21 1-20 TABLET changed over time?
Over the history we have for it, the NADAC for MICROGESTIN 21 1-20 TABLET has risen 11.9%. It has been tracked across 97 weekly CMS publications since Nov 27, 2024.
What are the highest and lowest recorded NADAC prices for MICROGESTIN 21 1-20 TABLET?
Since Nov 27, 2024, the NADAC for MICROGESTIN 21 1-20 TABLET has ranged from a low of $0.1619 (Nov 27, 2024) to a high of $0.1842 (Sep 16, 2026), with a median of $0.1722 per EA.
Are there cheaper alternatives to MICROGESTIN 21 1-20 TABLET?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MICROGESTIN 21 1-20 TABLET, is $0.1703 per EA — about 6% below MICROGESTIN 21 1-20 TABLET.
Who manufactures MICROGESTIN 21 1-20 TABLET?
MICROGESTIN 21 1-20 TABLET (NDC 75907008421) is labeled by Dr. Reddy's Laboratories Inc., and CMS classifies it as a generic product.